Accounts receivable rose 29.3%.
That is the oddest number in Privia Health's latest filing, because revenue grew 21.4% in the three months ended June 30, 2026. The business added $111.4 million of revenue year over year, but its receivables grew by $130.2 million.
The income statement looks cleaner at first glance. Operating income increased from $3.3 million to $11.8 million, lifting operating margin from 0.6% to 1.9%. Net income rose from $2.7 million to $9.0 million, though the diluted share count also increased 2.6%.
Privia attributes the sales growth to more providers, more visits, and more patients assigned to its capitated and Medicare programs. The biggest piece was fee-for-service patient-care revenue, which added $81.2 million.
Management's explanation is unusually specific:
"Key drivers of this revenue growth include: FFS–patient care revenue, which increased $81.2 million, primarily attributable to the addition of new providers and increase in visit volume; an increase in capitated revenue of $19.6 million due to an increase in Attributed Lives related to capitated arrangements; an increase in shared savings revenue of $8.9 million during the three months ended June 30, 2026, primarily due to timing of certain shared savings accruals and settlements; an increase in Attributed Lives in Medicare programs and continued strong performance in our value based care programs in the aggregate; and an increase in PMPM revenue of $3.8 million, primarily due to increased Attributed Lives."
Privia Health, 10-Q, Aug. 6, 2026.
So the growth is not a single-product story. It spans provider additions, visit volume, value-based care, and patient attribution. Shared-savings timing contributed too, which gives part of the increase a less repeatable flavor without making it the whole explanation.
The margin improvement also came with higher provider-related costs. Privia said distributions to providers were affected by timing, while provider expenses increased alongside fee-for-service and value-based-care revenue.
"The change is primarily due to the timing of distributions to providers partially offset by an increase in Implemented Providers and an increase in provider expenses related to the increase in FFS and VBC revenue."
Privia Health, 10-Q, Aug. 6, 2026.
That sentence helps explain why a 21.4% sales increase translated into a larger percentage increase in operating income. It does not settle the receivables question. Cash rose 5.7% to $412.2 million, slower than accounts receivable, which reached $574.2 million. Privia does not disclose the cause of that gap in the supplied filing details.
The company's annual record adds context without removing the tension. Revenue rose 22.3% in 2025, while operating margin reached 1.6%, suggesting the latest period continues a recent pattern of fast growth and narrow profitability. At 134.8 times trailing earnings, that slim margin matters to how much weight investors may put on each incremental dollar of profit.
The next disclosure to compare is Privia's next quarterly report, specifically the relationship between accounts receivable, cash, and revenue after this period's provider and patient growth.
The income statement shows growth, with receivables moving faster still.
Source: Privia Health 10-Q filed Aug. 6, 2026; comparative figures cover the three months ended June 30.